Bristol-Myers Squibb Company
SUBSTITUTED INDOLE ETHER COMPOUNDS

Last updated:

Abstract:

Disclosed are compounds of Formula (I) (I) N-oxides, or salts thereof, wherein R.sub.1, G, A, R.sub.5, and n are defined herein. Also disclosed are methods of using such compounds as inhibitors of signaling through Toll-like receptor 7, or 8, or 9, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating inflammatory and autoimmune diseases. ##STR00001##

Status:
Application
Type:

Utility

Filling date:

14 Dec 2018

Issue date:

11 Mar 2021